Yo Murakami
Shimane University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yo Murakami.
Journal of Stroke & Cerebrovascular Diseases | 2013
Yukie Satou; Hiroaki Oguro; Yo Murakami; Keiichi Onoda; Shingo Mitaki; Chizuko Hamada; Ryo Mizuhara; Shuhei Yamaguchi
BACKGROUND Patients who are unable to eat or drink after stroke may receive percutaneous endoscopic gastrostomy (PEG) or nasogastric tube feeding. Although the most common serious complication is well known to be aspiration pneumonia, the role of gastroesophageal reflux (GER) has not been fully assessed. The aim of this study was to examine, by means of 24-hour esophageal pH monitoring, whether GER is related to aspiration pneumonia and whether the size and laterality of brain lesions influence GER. METHODS Sixteen stroke patients were examined using a Degitrapper pH400 (Medtronic Japan Co., Tokyo, Japan) and Zinetics 24ME multiuse pH catheter (Medtronic). All patients had stroke lesions in the territory of the left or right middle cerebral artery that were confirmed by magnetic resonance imaging (MRI) and were receiving PEG or nasogastric feeding. Stroke volume was measured with MRIcron software. RESULTS Nine patients (56%) were diagnosed with GER, and 10 (63%) developed aspiration pneumonia after enteral feeding. The rate of aspiration pneumonia was significantly higher in patients with GER (88.9%) than in those without GER (42.9%; P = .04). Patients with left hemispheric lesions had a significantly higher incidence of acid reflex than those with right lesions (116 ± 105 vs 13 ± 17; P = .04). There were no significant differences in total time of acid reflux or mean pH value between patients with left and right hemispheric lesions. The lesion volume had no significant effect on any of 3 indices of GER. CONCLUSIONS GER is associated with aspiration pneumonia and occurs more often in patients with stroke lesions in the left hemisphere.
The American Journal of the Medical Sciences | 2005
Nobuyuki Takahashi; Toshio Shimada; Yo Murakami; Harumi Katoh; Nobuyuki Oyake; Yutaka Ishibashi; Ichizo Nishino; Ikuya Nonaka; Yu-ichi Goto
A 26-year-old man with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) was admitted to our hospital for further cardiovascular examination. A muscle biopsy demonstrated strongly succinate dehydrogenase-reactive blood vessels. Pulse wave contour analysis revealed that both capacitive and oscillatory compliance were markedly reduced in this patient compared with 45 normal age-matched control subjects. Hepatocyte growth factor was remarkably elevated in this patient over that of 10 normal control subjects. These findings suggest that a MELAS patient has not only pathologic but also functional vascular involvement. If so, patients with MELAS need systemic vascular assessment.
The American Journal of the Medical Sciences | 2006
Nobuyuki Takahashi; Toshio Shimada; Yutaka Ishibashi; Takashi Sugamori; Yoshifumi Hirano; Nobuyuki Oyake; Yo Murakami
There are few reports of cardiac involvement in patients with Kugelberg-Welander disease. We report a case of a 51-year-old man with Kugelberg-Welander disease who presented with syncope. His electrocardiogram showed complete right bundle branch block and transient complete atrioventricular block without escape rhythm. He was successfully treated with emergency temporary pacing followed by permanent pacemaker implantation. In this report, we review the relevant literature and argue that patients with Kugelberg-Welander disease should be evaluated regularly for cardiac disease.
Clinical and Experimental Pharmacology and Physiology | 2006
Shuzo Ohata; Yutaka Ishibashi; Toshio Shimada; Nobuyuki Takahashi; Takashi Sugamori; Takeshi Sakane; Yoshifumi Hirano; Nobuyuki Oyake; Yo Murakami; Tetsuya Higami
1 Previous clinical studies with prostaglandin I2 (PGI2) analogue beraprost sodium suggested the potential effects on protection of cardiovascular events in patients with peripheral artery disease. Although the mechanism is not well known, experimental studies have shown protective effects of endothelial cells. This study was designed to examine the effects of beraprost sodium on vascular endothelial function in the forearm of patients with coronary artery disease. 2 Beraprost sodium (120 mg/day) was orally administered to 14 coronary artery disease patients for 4 weeks and then stopped for 4 weeks. Eleven control patients did not receive beraprost sodium treatment. Reactive hyperemia was induced in the forearm, endothelium‐dependent vasodilatation was assessed by plethysmography, and urinary 8‐iso‐prostaglandin F2a (8‐iso‐PGF2a) was measured at baseline, 4 weeks and 8 weeks. 3 Both groups had similar reactive hyperemic responses at baseline. In the control group, reactive hyperemic response and urinary 8‐iso‐PGF2a remained unchanged for 8 weeks. In the beraprost group, maximum forearm blood flow increased significantly (P = 0.01) after 4 weeks of treatment and returned to baseline at 8 weeks. Duration of hyperemia increased significantly (P = 0.003) after 4 weeks, and remained greater than baseline at 8 weeks (P = 0.02). Urinary 8‐iso‐PGF2a decreased significantly (P = 0.03) after 4 weeks, and tended to be lower at 8 weeks (P = 0.07). Changes in reactive hyperemia correlated weakly but significantly with changes in 8‐iso‐PGF2a (P < 0.001). 4 Beraprost sodium decreased oxidative stress and improved forearm endothelium‐dependent vasodilatation in coronary artery disease patients. The favorable effects on vascular endothelium could potentially lead to a decrease in vascular events.
International Journal of Cardiology | 2011
Nobuyuki Takahashi; Toshio Shimada; Kazuaki Tanabe; Hiroyuki Yoshitomi; Yo Murakami; Yutaka Ishibashi; Reiko Kikkawa; Seiji Yano; Asuka Araki; Akira Inoue
A 66-year-old Japanese woman was urgently referred to our hospital. Two days prior to admission, her general practitioner began to administer prednisolone for treatment of a diagnosis of polymyalgia rheumatica. At the time of admission, laboratory results indicated multiorgan failure with rhabdomyolysis. Abdominal ultrasonography and computed tomography revealed a tumor in the right adrenal gland. On the same day, we measured serum and urine cathecholamines, which were markedly elevated. Additionally, magnetic resonance imaging revealed an adrenal mass and metaiodobenzylguanidine scintigraphy showed labeling of the tumor. Then, the patient underwent surgical resection of the tumor via laparoscopy. Histological examination confirmed the diagnosis of pheochromocytoma. One week after the operation, serum and urinary catecholamine levels returned to normal. The patient was discharged 10 days after the operation, and has remained stable at home. This report indicates that steroid should be avoided if possible in patients with pheochromocytoma. Furthermore, pheochromocytoma should be recalled as a differential diagnosis whenever patients take a sudden turn for the worse, or have acute uncontrollable hypertension following steroid administration and/or whenever patients present with unexplained rhabdomyolysis.
International Journal of Cardiology | 2009
Nobuyuki Takahashi; Toshio Shimada; Yutaka Ishibashi; Hiroyuki Yoshitomi; Takashi Sugamori; Takeshi Sakane; Hidetoshi Sato; Nobuyuki Oyake; Yo Murakami
We report a case of a 60-year-old woman. She was transferred from a local hospital to our cardiovascular medicine department with a diagnosis of infectious endocarditis due to Staphylococcus lugdunensis. Transthoracic echocardiograph confirmed the presence of large vegetations on the native aortic and mitral valve, and subsequent severe regurgitation due to the aortic and mitral valve destruction. Emergent operation was performed and patients life was barely rescued. However, S. lugdunensis belongs to coagulase-negative staphylococci, which are generally regarded as relatively avirulent bacterium, the endocarditis caused by S. lugdunensis can be invasive and often resembles endocarditis due to Staphylococcus aureus. Therefore, whenever this organism is found in patients with endocarditis, early surgical treatment of the infected valve should be considered.
American Journal of Cardiology | 1997
Yo Murakami; Yuji Ishinaga; Kazuya Sano; Yoshihisa Kinoshita; Jun Kitamura; Seiji Okada; Toshio Shimada
Transcardiac serotonin differences in nonischemic patients with endothelial dysfunction significantly increased in the early morning. Platelet secretion could occur without coronary stenosis.
American Journal of Cardiology | 1999
Toshio Shimada; Yo Murakami; Michio Hashimoto; Yutaka Ishibashi; Shin-ichi Inoue; Harumi Katoh; Yuji Ishinaga; Sumio Masumura
Simultaneous assessment of plasma nitrate/nitrite and serotonin levels revealed possible impairment of serotonin-mediated nitric oxide release in patients with coronary spastic angina.
Clinical and Experimental Pharmacology and Physiology | 2004
Harumi Katoh; Toshio Shimada; Shin-ichi Inoue; Nobuyuki Takahashi; Hiromi Shimizu; Yoko Ohta; Ko Nakamura; Yo Murakami; Yutaka Ishibashi; Akira Matsumori
1. Serum hepatocyte growth factor (HGF) is considered to be a potent marker of vascular endothelial injury. The present study was designed to examine serum HGF levels in atrial fibrillation and after successful direct current (DC) cardioversion.
Catheterization and Cardiovascular Diagnosis | 1996
Jun Kitamura; Yo Murakami; Toshio Shimada; Kouichi Ochiai; Kazuaki Tanabe; Hiroyuki Yoshitomi; Kazuya Sano; Rinji Murakami; Shigefumi Morioka
We report a case of superior vena cava (SVC) syndrome that was assessed by intravascular ultrasound (IVUS). A highly echogenic eccentric lesion was demonstrated by IVUS. The use of IVUS also confirmed in vivo that SVC syndrome following pacemaker insertion occurs as a result of intimal thickening of the venous wall.